168 related articles for article (PubMed ID: 27595159)
1. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1.
Jaramillo-Valverde L; Levano KS; Villanueva I; Hidalgo M; Cornejo M; Mazzetti P; Cornejo-Olivas M; Sanchez C; Poterico JA; Valdivia-Silva J; Guio H
Mol Genet Genomic Med; 2019 Oct; 7(10):e00960. PubMed ID: 31464097
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barré syndrome.
Prasad KN; Nyati KK; Verma A; Rizwan A; Paliwal VK
Hum Immunol; 2010 Sep; 71(9):905-10. PubMed ID: 20600447
[TBL] [Abstract][Full Text] [Related]
4. Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Kharwar NK; Prasad KN; Paliwal VK; Modi DR
J Neurol Sci; 2016 Apr; 363():57-62. PubMed ID: 27000222
[TBL] [Abstract][Full Text] [Related]
5. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Nyati KK; Prasad KN; Verma A; Singh AK; Rizwan A; Sinha S; Paliwal VK; Pradhan S
J Neuroimmunol; 2010 Jan; 218(1-2):116-9. PubMed ID: 19913922
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 promoter polymorphisms and haplotypes in patients with Guillain-Barré syndrome.
Hayat S; Asad A; Munni MA; Nayeem MAJ; Mostafa MG; Jahan I; Howlader MZH; Mohammad QD; Islam Z
Ann Clin Transl Neurol; 2024 Jan; 11(1):133-142. PubMed ID: 37955408
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barré syndrome.
Liu H; Xing Y; Guo Y; Liu P; Zhang H; Xue B; Shou J; Qian J; Peng J; Wang R; Gao Y; Fang S
J Neurol Sci; 2016 Oct; 369():39-42. PubMed ID: 27653862
[TBL] [Abstract][Full Text] [Related]
8. No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barré Syndrome in a Brazilian population.
Dourado ME; Ferreira LC; Freire-Neto FP; Jeronimo SM
J Neuroimmunol; 2016 Sep; 298():160-4. PubMed ID: 27609290
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.
Kuijf ML; Geleijns K; Ennaji N; van Rijs W; van Doorn PA; Jacobs BC
J Neuroimmunol; 2008 Dec; 205(1-2):110-2. PubMed ID: 18838176
[TBL] [Abstract][Full Text] [Related]
10. CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barré syndrome in the Bangladeshi population.
Rahman MI; Jahan I; Khalid MM; Jahan I; Ahammad RU; Nahar S; Islam Z
J Neuroimmunol; 2018 Jan; 314():8-12. PubMed ID: 29301656
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
Hayat S; Asad A; Hasan I; Jahan I; Papri N; Howlader ZH; Islam Z
Acta Neurol Scand; 2022 Aug; 146(2):177-185. PubMed ID: 35652365
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study in Guillain-Barré syndrome.
Blum S; Ji Y; Pennisi D; Li Z; Leo P; McCombe P; Brown MA
J Neuroimmunol; 2018 Oct; 323():109-114. PubMed ID: 30196823
[TBL] [Abstract][Full Text] [Related]
13. Association of tumor necrosis factor polymorphisms with Guillain-Barré syndrome.
Zhang J; Dong H; Li B; Li CY; Guo L
Eur Neurol; 2007; 58(1):21-5. PubMed ID: 17483581
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-4 299Gly allele is associated with Guillain-Barré syndrome in Bangladesh.
Jahan I; Ahammad RU; Khalid MM; Rahman MI; Hayat S; Islam B; Mohammad QD; Islam Z
Ann Clin Transl Neurol; 2019 Apr; 6(4):708-715. PubMed ID: 31019995
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
Das A; Khurshid S; Hayat S; Ahmed R; Islam Z
J Neuroimmunol; 2020 Nov; 348():577388. PubMed ID: 32949992
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barré syndrome in Bangladesh.
Jahan I; Ahammad RU; Farzana KS; Khalid MM; Islam MB; Rahman MI; Nahar S; Kabir Y; Mohmmad QD; Islam Z
J Neuroimmunol; 2017 Sep; 310():46-50. PubMed ID: 28778444
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
[TBL] [Abstract][Full Text] [Related]
18. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.
Islam Z; Jahan I; Ahammad RU; Shahnaij M; Nahar S; Mohammad QD
PLoS One; 2018; 13(2):e0192703. PubMed ID: 29432441
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA-DR/DQ polymorphisms with Guillain-Barré syndrome in Tunisian patients.
Fekih-Mrissa N; Mrad M; Riahi A; Sayeh A; Zaouali J; Gritli N; Mrissa R
Clin Neurol Neurosurg; 2014 Jun; 121():19-22. PubMed ID: 24793468
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome.
Myhr KM; Vågnes KS; Marøy TH; Aarseth JH; Nyland HI; Vedeler CA
J Neuroimmunol; 2003 Jun; 139(1-2):81-3. PubMed ID: 12799024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
